| Literature DB >> 30042300 |
Luís Amaro1, Daniela M Correia2,3, Teresa Marques-Almeida4, Pedro M Martins5,6, Leyre Pérez7,8, José L Vilas9,10, Gabriela Botelho11, Senentxu Lanceros-Mendez12,13, Clarisse Ribeiro14,15.
Abstract
Polymer-based piezoelectric biomaterials have already proven their relevance for tissue engineering applications. Furthermore, the morphology of the scaffolds plays also an important role in cell proliferation and differentiation. The present work reports on poly(hydroxybutyrate-co-hydroxyvalerate) (PHBV), a biocompatible, biodegradable, and piezoelectric biopolymer that has been processed in different morphologies, including films, fibers, microspheres, and 3D scaffolds. The corresponding magnetically active PHBV-based composites were also produced. The effect of the morphology on physico-chemical, thermal, magnetic, and mechanical properties of pristine and composite samples was evaluated, as well as their cytotoxicity. It was observed that the morphology does not strongly affect the properties of the pristine samples but the introduction of cobalt ferrites induces changes in the degree of crystallinity that could affect the applicability of prepared biomaterials. Young's modulus is dependent of the morphology and also increases with the addition of cobalt ferrites. Both pristine and PHBV/cobalt ferrite composite samples are not cytotoxic, indicating their suitability for tissue engineering applications.Entities:
Keywords: biomaterials; cobalt ferrites; poly(hydroxybutyrate-co-hydroxyvalerate); tissue engineering
Mesh:
Substances:
Year: 2018 PMID: 30042300 PMCID: PMC6121965 DOI: 10.3390/ijms19082149
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1PHBV morphologies: (a) neat PHBV films; (b) CFO films; (c) R fibers; (d) O fibers; (e) R CFO fibers; (f) O CFO fibers; (g) neat PHBV microspheres; (h) CFO microspheres; (i) scaffolds; (j) CFO scaffolds. The histograms with the corresponding fiber, sphere, and pore diameters are presented as figure inset.
Figure 2FTIR-ATR spectra of the (a) neat PHBV processing into different morphologies and (b) PHBV/CFO film composites.
Figure 3DSC thermograms for (a) different neat PHBV morphologies and (b) PHBV films and films composites.
T, ΔH, and crystallinity degree of all PHB and PHBV composite samples. The associated error is ±2%.
| Sample | Δ | ||
|---|---|---|---|
| Film | 174 | 82 | 56 |
| Film/CFO | 177 | 70 | 48 |
| R fibers | 175 | 98 | 67 |
| R/CFO fibers | 177 | 67 | 46 |
| O fibers | 177 | 65 | 45 |
| O/CFO fibers | 179 | 79 | 54 |
| Microsphere | 175 | 57 | 39 |
| Microsphere/CFO | 174 | 57 | 39 |
| Scaffold | 177 | 63 | 43 |
| Scaffold/CFO | 182 | 61 | 42 |
Figure 4TGA thermograms and corresponding first derivatives for (a) different neat PHBV morphologies and (b) PHBV films and films composites.
Figure 5Room temperature hysteresis curves for the CFO/PHBV composites.
Water contact angle measurement for the different samples (mean ± SD).
| Film | Film CFO | Fibers O | Fibers O CFO | Fibers R | Fibers R CFO | Scaffold | Scaffold CFO |
|---|---|---|---|---|---|---|---|
| 90 ± 12° | 96 ± 4° | 103 ± 11° | 119 ± 5° | 125 ± 2° | 128 ± 2° | 97 ± 13° | 106 ± 9° |
Figure 6Mechanical stress-strain behavior of the different PHBV samples with and without CFO.
Young’s modulus of the different PHBV samples. Values shown as mean ± SD.
| Morphologies | E (MPa) |
|---|---|
| Film | 17 ± 5 |
| Film CFO | 27 ± 5 |
| Fibers R | 1.1 ± 0.6 |
| Fibers R CFO | 1.7 ± 0.5 |
| Fibers O | 66 ± 41 |
| Fibers O CFO | 83 ± 9 |
| Scaffold | 8.9 × 10−3 ± 1.7 × 10−3 |
| Scaffold CFO | 1.3 × 10−2 ± 6.4 × 10−4 |
Figure 7(a) Young’s modulus of the PHBV scaffolds with and without CFO along the compression cycles and (b) characteristic stress–strain curves of the PHBV scaffolds with CFO for compression assays at 10%.
Figure 8Cytotoxicity assay of MC3T3-E1 pre-osteoblast cells in contact with the as-prepared extraction media exposed to the different PHBV samples for 72 h (relative cell viability was presented as the percentage of the negative control (n = 4 ± SD).
Figure 9Schematic representation of the processing of the PHBV films by solvent casting.
Figure 10Schematic representation of the processing of the electrospun fibers.
Figure 11Schematic representation of the oil-in-water emulsion method for the preparation of microspheres.
Figure 12Schematic representation of the preparation procedure of the PHBV scaffolds.
Procedures for the processing of PHBV and PHBV/CFO composites into different morphologies.
| Nomenclature | Composition | Morphology | Processing Technique |
|---|---|---|---|
| Film | PHBV | Film | Solvent-casting |
| Film CFO | PHBV, CoFe2O4 | ||
| Fibers R | PHBV | Randomly oriented fibers | Electrospinning |
| Fibers R CFO | PHBV, CoFe2O4 | ||
| Fibers O | PHBV | Oriented fibers | |
| Fibers O CFO | PHBV, CoFe2O4 | ||
| Microspheres | PHBV | Microspheres | Oil/water emulsion |
| Microspheres CFO | PHBV, CoFe2O4 | ||
| Scaffold | PHBV | 3D Scaffold | Solvent-casting/particulate leaching |
| Scaffold CFO | PHBV, CoFe2O4 |